An Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer
Open Access
- 15 January 2016
- journal article
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 48 (1) , 259-265
Abstract
Adjuvant chemoradiation following primary surgery is frequently indicated in patients with Stage IB cervical cancer. The aim of this study is to evaluate the role of an MRI-based strategy in avoiding trimodality therapy.We retrospectively reviewed all patients with Stage IB cervical cancer treated initially with primary surgery at Seoul National University Hospital. We suggest an alternative triage strategy in which the primary treatment modality is determined based on preoperative MRI findings. Using this strategy, primary surgery is only indicated when there is no evidence of parametrial involvement (PMI) and lymph node metastasis (LNM) in the MRI results; when there is evidence of either or both of these factors, primary chemoradiation is selected. Assuming that this strategy is applied to our cohort, we evaluate how the rate of trimodality therapy is affected.Of the 254 patients in our sample, 77 (30.3%) had at least one Category 1 risk factor (PMI, LNM, positive resection margin) upon pathologic examination. If the MRI-based strategy had been applied to our cohort, 168 patients would have undergone primary surgery and 86 would have undergone primary chemoradiation. Only 25 patients (9.8%) would have required trimodality therapy based on an indication of at least one Category 1 pathologic risk factor following radical hysterectomy.The inclusion of MRI in the decision-making process for primary treatment modality could have reduced the number of patients requiring trimodality therapy based on the indication of a Category 1 risk factor from 30.3% to 9.8% in our cohort.Keywords
This publication has 23 references indexed in Scilit:
- Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011Cancer Research and Treatment, 2014
- Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancerJournal of Gynecologic Oncology, 2012
- Treatment patterns of FIGO Stage IB2 cervical cancer: A single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapyGynecologic Oncology, 2008
- Management of cervical cancer: summary of SIGN guidelinesBMJ, 2008
- Quality of Life and Sexual Functioning in Cervical Cancer SurvivorsJournal of Clinical Oncology, 2005
- Utilization of Diagnostic Studies in the Pretreatment Evaluation of Invasive Cervical Cancer in the United States: Results of Intergroup Protocol ACRIN 6651/GOG 183Journal of Clinical Oncology, 2005
- Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancerThe Lancet, 1997
- Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapyGynecologic Oncology, 1990
- Complications of combined radical hysterectomy—Postoperative radiation therapy in women with early stage cervical cancerGynecologic Oncology, 1989
- Sexual dysfunction and treatment for early stage cervical cancerCancer, 1989